» Articles » PMID: 22148102

Vagal Control of Satiety and Hormonal Regulation of Appetite

Overview
Date 2011 Dec 8
PMID 22148102
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The paradigm for the control of feeding behavior has changed significantly. In this review, we present evidence that the separation of function in which cholecystokinin (CCK) controls short-term food intake and leptin regulate long-term eating behavior and body weight become less clear. In addition to the hypothalamus, the vagus nerve is critically involved in the control of feeding by transmitting signals arising from the upper gut to the nucleus of the solitary tract. Among the peripheral mediators, CCK is the key peptide involved in generating the satiety signal via the vagus. Leptin receptors have also been identified in the vagus nerve. Studies in the rodents clearly indicate that leptin and CCK interact synergistically to induce short-term inhibition of food intake and long-term reduction of body weight. The synergistic interaction between vagal CCK-A receptor and leptin is mediated by the phosphorylation of signal transducer and activator of transcription3 (STAT3), which in turn, activates closure of K(+) channels, leading to membrane depolarization and neuronal firing. This involves the interaction between CCK/SRC/phosphoinositide 3-kinase cascades and leptin/Janus kinase-2/phosphoinositide 3-kinase/STAT3 signaling pathways. It is conceivable that malfunctioning of these signaling molecules may result in eating disorders.

Citing Articles

The endocannabinoid system in appetite regulation and treatment of obesity.

Kurtov M, Rubinic I, Likic R Pharmacol Res Perspect. 2024; 12(5):e70009.

PMID: 39292202 PMC: 11409765. DOI: 10.1002/prp2.70009.


Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus.

Hoekx C, Straat M, Bizino M, van Eyk H, Lamb H, Smit J Exp Physiol. 2024; 109(8):1292-1304.

PMID: 38965822 PMC: 11291866. DOI: 10.1113/EP091815.


Weight Regain after Metabolic Surgery: Beyond the Surgical Failure.

Salazar J, Duran P, Garrido B, Parra H, Hernandez M, Cano C J Clin Med. 2024; 13(4).

PMID: 38398456 PMC: 10888585. DOI: 10.3390/jcm13041143.


Association of serum leptin and ghrelin levels with smoking status on body weight: a systematic review and meta-analysis.

Shaheen N, Shaheen A, Diab R, Saad A, Abdelwahab O, Soliman S Front Psychiatry. 2023; 14:1296764.

PMID: 38111614 PMC: 10725976. DOI: 10.3389/fpsyt.2023.1296764.


Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem.

Haspula D, Cui Z Cells. 2023; 12(13).

PMID: 37443835 PMC: 10341274. DOI: 10.3390/cells12131801.


References
1.
Burdyga G, Spiller D, Morris R, Lal S, Thompson D, Saeed S . Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience. 2002; 109(2):339-47. DOI: 10.1016/s0306-4522(01)00474-2. View

2.
Ebenezer I . The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis. Eur J Pharmacol. 2003; 461(2-3):113-8. DOI: 10.1016/s0014-2999(02)02916-3. View

3.
Phillips M, Liu Q, HAMMOND H, Dugan V, Hey P, Caskey C . Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 1996; 13(1):18-9. DOI: 10.1038/ng0596-18. View

4.
Weatherford S, Chiruzzo F, Laughton W . Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Am J Physiol. 1992; 262(4 Pt 2):R574-8. DOI: 10.1152/ajpregu.1992.262.4.R574. View

5.
Blackshaw L, Grundy D . Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J Auton Nerv Syst. 1990; 31(3):191-201. DOI: 10.1016/0165-1838(90)90185-l. View